AMAT
49
2
OI
58
-2
EOG
36
-9
O
31
-8
ALL
54
-6
TRIP
47
-5
JBHT
63
3
HUM
42
8
HD
32
-2
VNO
50
-2
BSX
60
3
PGR
40
-3
NRG
44
7
DHR
64
2
LYB
20
-3
LOW
67
18
GE
72
4
VIX
32
-12
CCI
34
-2
AVGO
42
18
AMAT
49
2
OI
58
-2
EOG
36
-9
O
31
-8
ALL
54
-6
TRIP
47
-5
JBHT
63
3
HUM
42
8
HD
32
-2
VNO
50
-2
BSX
60
3
PGR
40
-3
NRG
44
7
DHR
64
2
LYB
20
-3
LOW
67
18
GE
72
4
VIX
32
-12
CCI
34
-2
AVGO
42
18
Financhill
Back

STF Tactical Growth & Income ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
29

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.64
Seasonality Move:
-1.93%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Sell
29
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.29. The Score for TUGN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.56 Buy
Relative Strength Index (14 RSI): 41.52 Sell
Chaikin Money Flow: -2669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.59 Sell
20-day SMA: 25.6 Sell
50-day SMA: 25.92 Sell
200-day SMA: 24.29 Buy
8-day EMA: 9.96 Buy
20-day EMA: 4.57 Buy
50-day EMA: 1.94 Buy
200-day EMA: 0.5 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):